Category: Funding Opportunities

Change in Receipt Dates for NIGMS Research on Interventions Program


We recently published a notice (NOT-GM-20-050) announcing a single receipt date each year for our Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in Biomedical Sciences (R01/R35) program.

The purpose of the program is to better understand the factors (e.g., social and behavioral) contributing to the success of individuals pursuing independent academic biomedical research careers. It supports research to enhance evidence for effective, high-impact, scalable interventions that may be focused on training programs, psychosocial factors, critical career transition points, or institutional culture. Due in part to the small number of applications received in response to this funding opportunity, the change in the program’s receipt date will allow us to increase efficiencies in the grant application review process.

Continue reading “Change in Receipt Dates for NIGMS Research on Interventions Program”

Webinar for NIGMS Institutional Predoctoral Training Grant Program Applicants


UPDATE: The  video and slides [PDF] from the Predoctoral Training Grant (T32) webinar are now available.

If you’re planning to submit an application for the NIGMS Institutional Predoctoral Training Grant (T32) program in the basic biomedical sciences (PAR-20-213) for receipt dates on or after September 25, don’t miss our upcoming webinar:

Friday, August 28, 12:00-1:30 p.m. ET

Continue reading “Webinar for NIGMS Institutional Predoctoral Training Grant Program Applicants”

Funding Opportunities: Rapid Acceleration of Diagnostics Radical (RADx-rad) Emergency Awards


We’ve joined the NIH Office of the Director and several institutes in two Rapid Acceleration of Diagnostics Radical (RADx-rad) initiative funding opportunity announcements (FOAs). These FOAs offer an excellent opportunity for NIGMS-supported researchers with expertise in technology development and/or artificial intelligence/machine learning to conduct innovative research addressing the public health emergency caused by COVID-19.

Continue reading “Funding Opportunities: Rapid Acceleration of Diagnostics Radical (RADx-rad) Emergency Awards”

MOSAIC Announcements and Upcoming Webinar


UPDATE: The video and slides [PDF] from the MOSAIC webinar are now available.

Last summer, we shared with you our new Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) funding opportunity announcements (FOAs). MOSAIC, which NIGMS oversees, is part of NIH’s efforts to enhance diversity within the academic biomedical research workforce. It’s designed to facilitate the transition of promising postdoctoral researchers from diverse backgrounds into independent faculty careers at research-intensive institutions. The program has two components: a research education cooperative agreement (UE5) and a postdoctoral career transition award (K99/R00).

Continue reading “MOSAIC Announcements and Upcoming Webinar”

Changes to COBRE Phase 1 and Phase 2 Awards and Applications


We’d like to call your attention to a pair of recently published notices (NOT-GM-20-042 and NOT-GM-20-043) that address the unfavorable impact of the COVID-19 pandemic on institutions’ ability to recruit faculty investigators. In response to this, we’ve reduced the minimum number of research projects required for our Centers of Biomedical Research Excellence (COBRE) Phases 1 and 2 from three to two. Additionally, we’ll allow budget increases for recruitment costs and pilot projects. These changes apply to active awards and to applications submitted for new Phase 1 (PAR-19-313) and Phase 2 (PAR-19-312) funding opportunity announcements.

Continue reading “Changes to COBRE Phase 1 and Phase 2 Awards and Applications”

Webinar and Other Resources for New MIRA ESI Funding Opportunity


UPDATE: The video and slides [PDF] from the MIRA webinar are now available.

We recently reissued the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (PAR-20-117). The first application due date is October 2, 2020.

We’re hosting a webinar to discuss this FOA and to answer your questions about the program on Thursday, August 6, 1:00-2:30 p.m. ET. To access the webinar, visit the WebEx meeting page (link no longer available) and enter the meeting number 126 938 7475 and the password NIGMS. For an audio-only presentation, call 1-650-479-3208 (US/Canada) and enter access code 126 938 7475. We plan to post the archived webinar and slides on the MIRA webpage after the event.

Continue reading “Webinar and Other Resources for New MIRA ESI Funding Opportunity”

Webinar for IDeA-CTR Program Applicants


UPDATE: The video and slides [PDF] from the IDeA-CTR webinar are now available.

If you’re preparing an Institutional Development Award Networks for Clinical and Translational Research (IDeA-CTR) grant application for the October 7 receipt date, don’t miss our upcoming webinar:

Thursday, August 6, 3:00-4:30 p.m. ET

During the webinar, IDeA program staff will answer your questions about changes in the goals, objectives, and organizational structures of the IDeA-CTR program, as described in the funding opportunity announcement. Principal investigators who plan to submit new or renewal applications are encouraged to attend.

Continue reading “Webinar for IDeA-CTR Program Applicants”

ALS2 Funding Opportunity: Fundamental Research in Underlying Causes of Amyotrophic Lateral Sclerosis


We’re pleased to announce our participation in the Accelerating Leading-edge Science in ALS (ALS2) program (NOT-RM-20-019). ALS2 is a $25 million NIH Common Fund initiative to spur innovative research into the basic biology of amyotrophic lateral sclerosis (ALS) through the NIH Director’s Transformative Research Award. NIGMS encourages our community of basic scientists working on relevant processes to consider applying for this opportunity.

ALS is a devastating disease with no known cure. The development of effective therapeutics can benefit tremendously from basic ALS research that 1.) tests highly novel concepts, 2.) brings together researchers from different scientific perspectives, and 3.) applies powerful emerging technologies from a variety of disciplines.

Continue reading “ALS2 Funding Opportunity: Fundamental Research in Underlying Causes of Amyotrophic Lateral Sclerosis”

Webinar for Postdoctoral Research Associate Training (PRAT) Program Applicants


UPDATE: The video Link to external web site and slides [PDF, 5.23MB] from the PRAT webinar are now available.

We’re hosting a webinar for students and fellows interested in the PRAT Program for the October 2, 2020, receipt date:

Tuesday, July 14, 2:00-3:00 p.m. ET

PRAT is a competitive 3-year fellowship program that prepares trainees for leadership positions in biomedical careers. Training includes a mentored laboratory research experience and intensive career and leadership development activities. PRAT fellows conduct research in laboratories in the NIH Intramural Research Program (IRP) in basic biomedical research areas within the NIGMS mission. These areas include, but are not limited to, biological chemistry, biophysics, bioinformatics, cellular and molecular biology, computational biosciences, developmental biology, genetics, immunology, neuroscience, pharmacology, physiology, and technology development.

Continue reading “Webinar for Postdoctoral Research Associate Training (PRAT) Program Applicants”

NIGMS Priorities for Small Business Development of Sepsis Diagnostics and Therapeutics


Last summer, we published a notice of information on our priorities for sepsis research that applies to all active NIGMS funding opportunity announcements. We’ve now published a notice of special interest (NOT-GM 20-028) to promote early-stage research and development projects through the NIH SBIR/STTR program. 

We’re interested in receiving applications from small businesses or from small businesses and their academic partners that propose to develop novel tools and technologies for sepsis research, detection, and treatment. We’re specifically interested in diagnostic tools, predictive clinical algorithms, and technologies to facilitate molecular phenotyping of sepsis patients.

If you have any questions about NIGMS priorities for small business development of sepsis diagnostics and therapeutics, please contact me